Overview

Study to Evaluate the Long-term Safety of a Once-Daily Omiganan Topical Gel

Status:
Completed
Trial end date:
2018-02-08
Target enrollment:
Participant gender:
Summary
This study evaluates the long-term safety of once-daily application of Omiganan topical gel in subjects with severe papulopustular rosacea.
Phase:
Phase 3
Details
Lead Sponsor:
Cutanea Life Sciences, Inc.
Maruho Co., Ltd.